Opus Genetics (IRD) Property, Plant & Equipment (Net) (2010 - 2026)

Opus Genetics (IRD) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - 642,333.36
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn 518.26 Mn
10 Opus Genetics 280.22 Mn 220.22 Mn - 186,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 186,000.00
Mar 31, 2026 186,000.00
Dec 31, 2025 199,000.00
Dec 31, 2025 199,000.00
Sep 30, 2025 212,000.00
Sep 30, 2025 212,000.00
Jun 30, 2025 226,000.00
Jun 30, 2025 226,000.00
Mar 31, 2025 239,000.00
Mar 31, 2025 239,000.00
Dec 31, 2024 252,000.00
Dec 31, 2024 252,000.00
Sep 30, 2023 3,000.00
Sep 30, 2023 3,000.00
Jun 30, 2023 4,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 5,000.00
Mar 31, 2023 5,000.00
Dec 31, 2022 6,000.00
Dec 31, 2022 6,000.00